The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

Mathias Vilaine, Damla Olcaydu, Ashot Harutyunyan, Jonathan Bergeman, Mourad Tiab, Jean-François Ramée, Jian-Min Chen, Robert Kralovics, Sylvie Hermouet, Homologous recombination of wild-type JAK2, a novel early step in the development of myeloproliferative neoplasm. Blood. ,vol. 118, pp. 6468- 6470 ,(2011) , 10.1182/BLOOD-2011-08-372813

H Andrikovics, S Nahajevszky, M Koszarska, N Meggyesi, A Bors, G Halm, S Lueff, N Lovas, Z Matrai, J Csomor, R Rasonyi, M Egyed, J Varkonyi, G Mikala, A Sipos, A Kozma, E Adam, S Fekete, T Masszi, A Tordai, JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia Leukemia. ,vol. 24, pp. 1809- 1813 ,(2010) , 10.1038/LEU.2010.172

M Boissinot, C Cleyrat, M Vilaine, Y Jacques, I Corre, S Hermouet, Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F Oncogene. ,vol. 30, pp. 990- 1001 ,(2011) , 10.1038/ONC.2010.479

Amy V. Jones, Peter J. Campbell, Philip A. Beer, Susanne Schnittger, Alessandro M. Vannucchi, Katerina Zoi, Melanie J. Percy, Mary Frances McMullin, Linda M. Scott, William Tapper, Richard T. Silver, David Oscier, Claire N. Harrison, Harald Grallert, Aliaksei Kisialiou, Paul Strike, Andrew J. Chase, Anthony R. Green, Nicholas C. P. Cross, The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms Blood. ,vol. 115, pp. 4517- 4523 ,(2010) , 10.1182/BLOOD-2009-08-236448

Animesh Pardanani, Brooke L. Fridley, Terra L. Lasho, D. Gary Gilliland, Ayalew Tefferi, Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders. Blood. ,vol. 111, pp. 2785- 2789 ,(2008) , 10.1182/BLOOD-2007-06-095703

C Cleyrat, J Jelinek, F Girodon, M Boissinot, T Ponge, J-L Harousseau, J-P Issa, S Hermouet, JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5. Leukemia. ,vol. 24, pp. 1069- 1073 ,(2010) , 10.1038/LEU.2010.23

S. Nahajevszky, H. Andrikovics, A. Batai, E. Adam, A. Bors, J. Csomor, L. Gopcsa, M. Koszarska, A. Kozma, N. Lovas, S. Lueff, Z. Matrai, N. Meggyesi, J. Sinko, A. Sipos, A. Varkonyi, S. Fekete, A. Tordai, T. Masszi, The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia. Haematologica. ,vol. 96, pp. 1613- 1618 ,(2011) , 10.3324/HAEMATOL.2011.043885

Outi Kilpivaara, Semanti Mukherjee, Alison M Schram, Martha Wadleigh, Ann Mullally, Benjamin L Ebert, Adam Bass, Sachie Marubayashi, Adriana Heguy, Guillermo Garcia-Manero, Hagop Kantarjian, Kenneth Offit, Richard M Stone, D Gary Gilliland, Robert J Klein, Ross L Levine, A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms Nature Genetics. ,vol. 41, pp. 455- 459 ,(2009) , 10.1038/NG.342

Ralph Tiedt, Hui Hao-Shen, Marta A. Sobas, Renate Looser, Stephan Dirnhofer, Jürg Schwaller, Radek C. Skoda, Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice Blood. ,vol. 111, pp. 3931- 3940 ,(2007) , 10.1182/BLOOD-2007-08-107748

Damla Olcaydu, Ashot Harutyunyan, Roland Jäger, Tiina Berg, Bettina Gisslinger, Ingrid Pabinger, Heinz Gisslinger, Robert Kralovics, A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms Nature Genetics. ,vol. 41, pp. 450- 454 ,(2009) , 10.1038/NG.341